Related Experiment Video
Updated: Mar 1, 2026
09:09
Synthesis of Aptamer-PEI-g-PEG Modified Gold Nanoparticles Loaded with Doxorubicin for Targeted Drug Delivery
Published on: June 23, 2020
6.6K
Genomic DNA Interactions Mechanize Peptidotoxin-Mediated Anticancer Nanotherapy
Santosh K Misra1, Aaron S Schwartz-Duval1, Dipanjan Pan1
1Department of Bioengineering, Department of Materials Science and Engineering, and Beckman Institute, University of Illinois at Urbana-Champaign, Mills Breast Cancer Institute, and Carle Foundation Hospital , Urbana, Illinois 61801, United States.
Molecular Pharmaceutics
|May 26, 2017
Summary
Host defense peptides, or peptidotoxins, show anticancer potential. Nano-delivery systems enable controlled intracellular delivery, revealing their ability to regulate cell cycles and inhibit cancer growth via genomic DNA interaction.
Area of Science:
- Biochemistry
- Nanotechnology
- Immunology
Background:
- Host defense peptides (HDPs) are crucial for innate immunity.
- Peptidotoxins, a subset of HDPs, show promise for anticancer therapy but face challenges due to off-target toxicity.
- Controlled delivery is essential to harness their therapeutic potential.
Purpose of the Study:
- To develop a nanoarchitecture for controlled intracellular delivery of peptidotoxins.
- To investigate the interaction of peptidotoxins with genomic DNA.
- To elucidate the mechanism of peptidotoxins' anticancer activity.
Main Methods:
- Synthesis of a rigid-cored polymeric nanoarchitecture using amphiphilic polymers.
- Delivery of model peptidotoxins (melittin, TSAP-1) using the nanoarchitecture.
- Biophysical characterization including UV-vis spectroscopy, gel electrophoresis, MTT assay, and flow cytometry.
Main Results:
- The nanoarchitecture facilitated controlled intracellular delivery of peptidotoxins.
- Peptidotoxins demonstrated significant interaction with duplex plasmid DNA in vitro.
- This interaction influenced cancer cell growth and cell cycle regulation.
Conclusions:
- Nanoenabled delivery of peptidotoxins can overcome toxicity issues.
- Peptidotoxins exert anticancer effects by interacting with and regulating genomic DNA.
- This mechanism highlights a novel pathway for cancer therapy development.
Related Concept Videos
02:57Targeted Cancer Therapies
9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.0K
02:50Combination Therapies and Personalized Medicine
6.3K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.3K
02:56Treatment Resistant Cancers
3.8K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K
01:27Tumor Immunotherapy
2.1K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
01:25Drug-Receptor Bonds
5.1K
Drug-receptor bonds are formed through various chemical forces when drugs interact with target cells. Covalent bonds, strong and irreversible, are exemplified by DNA-alkylating anticancer agents that inhibit cell division. However, such irreversible drug binding lacks selectivity and can modify the DNA of the surrounding healthy cells. Covalent binding often contributes to tissue toxicity, as seen with chloroform and paracetamol metabolites binding to the liver, causing hepatotoxicity.
In...
In...
5.1K